Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 10, 1997, Pages 3408-3413

  Mantzoros, Christos S ^a   Moschos, Stergios ^a   Avramopoulos, Iraklis ^b   Kaklamani, Virginia ^a   Liolios, Antonios ^c   Doulgerakis, Dimitrios E ^c   Griveas, Ioannis ^c   Katsilambros, Nicholas ^b   Flier, Jeffrey S ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c 401 Military Hospital   (Greece)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; LEPTIN; MALE; OSMOLAR CONCENTRATION; PROTEINS; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

RODENTIA;

EID: 0030884125     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.10.3408     Document Type: Article

References (66)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. 1994 Positional cloning of the mouse ob gene and its human homologue. Nature. 372:425-432.
2. Frederich RC, Hamann A, Anderson S, Lollman B, Lowell BB, Flier JS. 1995 Leptin reflects body lipid content in mice: evidence for diet-induced leptin resistance. Nature Med. 1:1311-1314.
3. Spiegelman BM, Flier JS. 1996 Adipogenesis and obesity. Rounding out the big picture. Cell. 87:377-389.
4. Rink TJ. 1995 In search of a satiety factor. Nature. 372:406-407.
5. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. 1996 Leptin: the tale of an obesity gene. Diabetes. 45:1455-1462.
6. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P. 1995 Recombinant mouse ob protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 269:546-548.
7. Halaas JL, Gajiwala KS, Maffei M, et al. 1995 Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 269:543-546.
8. Pelleymounter MA, Cullen MJ, Baker MB, et al. 1995 Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 269:540-543.
9. Weigle DS, Bukowski TR, Foster DC, et al. 1995 Recombinant ob protein reduces feeding and body weight in the ob/ob mouse. J Clin Invest. 96:2065-2070.
10. Hotamisligil GS, Peraldi P, Spiegelman BM. 1996 The molecular link between obesity and diabetes. Curr Opin Endocr Diabetes. 3:16-23.
11. Grunfeld C, Zhao C, Fuller J, et al. 1996 Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 97:2152-2157.
12. Sarraf P, Frederick RC, Turner EM, et al. 1997 Multiple cytokines and acute inflammation raise mouse leptin levels: potential role in inflammatory anorexia. J Exp Med. 185:171-175.
13. Considine RV, Sinha MK, Heiman ML, et al. 1996 Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Engl J Med. 334:292-295.
14. Maffei M, Halaas J, Ravussin E, et al. 1995 Leptin levels inhuman and rodent: measurement of plasma leptin and ob mRNA in obese and weight-reduced subjects. Nature Med. 1:1155-1161.
15. Toomey D, Redmond P, Bouchier-Hayes D. 1995 Mechanisms mediating cancer cachexia. Cancer. 76:2418-2426.
16. Staal van den Brekel AJ, Dentener MA, Schols AM, Buurman WA, Wouters EF. 1995 Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol. 13:2600-2605.
17. Tracey KJ, Cerami A. 1992 Tumor necrosis factor and regulation of metabolism in infection: role of systemic versus tissue levels. Proc Soc Exp Biol Med. 200:233-239.
18. Keller U. 1993 Pathophysiology of cancer cachexia. Support Care Cancer. 1:290-294.
19. Ojeda SR, Griffin JE. 1992 Organization of the endocrine system. In: Griffin JE, Ojeda SR (eds). Textbook of endocrine physiology. Oxford: Oxford University Press; 2nd ed.
20. Ahima RS, Prabakaran D, Mantzoros CS, Qu D, Lowell B, Maratos-Flier E, Flier JS. 1996 Role of leptin in the neuroendocrine response to fasting. Nature. 382:250-252.
21. Hotamisligil GS, Spiegelman BM. 1994 Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes. 43:1271-1278.
22. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995 Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 95:2409-2415.
23. Warzocha K, Bienvenu J, Coiffier B, Salles G. 1995 Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Eur Cytokine Netw. 6:83-96.
24. Diez-Ruiz A, Tilz GP, Zangerle R, Baier-Bitterlich G, Wachter H, Fuchs D. 1995 Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis. Eur J Haematol. 54:1-8.
25. Mantzoros CS, Georgiadis EI, Evangelopoulou K, Katsilambros N. 1996 Dehydroepiandrosterone sulfate and testosterone are independently associated with body fat distribution in premenopausal women. Epidemiology. 7:513-516.
26. Mantzoros CS, Dunaif A, Flier JS. 1997 Leptin concentrations in thepolycystic ovary syndrome. J Clin Endocrinol Metab. 82:1687-1691.
27. Modan M, Harris MI, Halkin H. 1989 Evaluation of WHO and NDDG criteria for impaired glucose tolerance. Diabetes. 38:1603-1635.
28. Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS, Kahn BB. 1996 Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes. 45:1638-1643.
29. Mantzoros CS, Rosen HN, Greenspan SL, Flier JS, Moses AC. 1997 Short-term hyperthyroidism has no effect on leptin levels in man. J Clin Endocrinol Metab. 82:497-499.
30. Hotamisligil GS, Arner P, Atkinson RL, Spiegelmen BM. 1997 Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes. 46:451-455.
31. Cusin I, Sainsbury A, Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. 1995 The ob gene and insulin. Diabetes. 44:1467-1470.
32. Saladin R, De Vos P, Guerre-Millo M, et al. 1995 Transient increase in obese gene expression after food intake or insulin administration. Nature. 377:527-529.
33. Leroy P, Dessolin S, Villageois P, et al. 1996 Expression of ob gene in adipose cells. J Biol Chem. 271:2365-2368.
34. Kolaczynski JW, Nyce MR, Considine RV, et al. 1996 Acute and chronic effect of insulin on leptin production in humans: studies in vivo and in vitro. Diabetes. 45:699-701.
35. Widjaja A, Stratton IM, Horn R, Holman RR, Turnenr R, Brabant G. 1997 UKPDS 20: Plasma leptin, obesity and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab. 82:654-657.
36. Segal KR, Landt M, Klein S. 1996 Relationship between insulin sensitivity and plasma leptin concentrations in lean and obese men. Diabetes. 45:988-991.
37. Haffner SM, Stern MP, Miettinen H, Wei M, Gingerich RL. 1996 Leptin concentrations in diabetic and nondiabetic mexican-americans. Diabetes. 45:822-824.
38. Sinha MK, Ohanessian JP, Heinman ML, Kriacinunas A, Stephens TN, Magosin SA, Marco C, Caro SF. 1996 Nocturnal rise of leptin in lean, obese, and noninsulin dependent diabetes mellitus subjects. J Clin Invest. 97:1344-1347.
39. Ronnemaa T, Karonen S-L, Rissanen A, Koskenvuo M, Koivisto VA. 1997 Relation between plasma leptin levels and measures of body fat in identical twins discordant for obesity. Ann Intern Med. 126:26-31.
40. Montague CT, Prins JB, Sanders L, Digby JE, O'Rahilly S. 1997 Depot- and sex-specific differences in human leptin mRNA expression. Diabetes. 46:342-347.
41. Heaney ML, Golde DW. 1993 Soluble hormone receptors. Blood. 82: 1945-1948.
42. Brockhaus M, Schoenfeld HJ, Schlager EJ, Hunziker W, Lesslauer W, Loetscher H. 1990 Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA. 87:3127-3131.
43. Loetscher H, Pan YE, Lahm HW, et al. 1990 Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell. 61:351-359.
44. Bemelmans MHA, van Tis LJH, Buurman WA. 1996 Tumor Necrosis Factor: Function, release and clearance. Crit Rev Immunol. 16:1-11.
45. Engelman H, Novick D, Wallach D. 1990 Two tumor necrosis factor-binding proteins purified from human urine: evidence from immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem. 265:1531.
46. Hohmann HP, Remy R, Brockhaus M, van Loon APGM. 1989 Two different cell types have different major receptors for human tumor necrosis factor (TNFα). J Biol Chem. 264:14927.
47. Aderka D, Engelmann H, Maor Y, Brockhaus C, Wallach D. 1992 Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 175:323-329.
48. Bonner JC, Brody AP. 1995 Cytokine-binding proteins in the lung. Am J Physiol. 12:L869-L878.
49. Tartaglia LA, Rothe M, Hu YF, Goeddel DV. 1993 Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor. Cell. 73:213.
50. Peraldi P, Hotamisligil GS, Buurman WA, White MF, Spiegelman BM. 1996 Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J Biol Chem. 271:13018-13022.
51. Moller B, Ellermann-Eriksen S, Storgard M, Obel N, Bendtzen K, Petersen CM. 1996 Soluble tumour necrosis factor (TNF) receptors conserve TNF bioactivity in meningitis patient spinal fluid. J Infect Dis. 174:557-563.
52. Steiner G, Studnicka-Benke A, Witzman G, Hofler E, Smolen J. 1995 Soluble receptors for tumour necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis, and osteoarthritis. J Rheumatol 1995;22:406-412.
53. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Sokol ML. 1996 Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol. 88:420-427.
54. Samsonov MY, Tilz GP, Egorova O, et al. 1995 Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus. Lupus. 4:29-32.
55. Schroder J, Stuber F, Galatti H, Schade FU, Kremer B. 1995 Pattern of soluble TNF receptors I and II in sepsis. Infection. 23:143-148.
56. Bilello JA, Stellrecht K, Drusano GL, Stein DS. 1996 Soluble tumor necrosis factor-alpha receptor type II correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. J Infect Dis. 173:464-7.
57. Gattorno M, Picco P, Buoncompagni A, et al. 1996 Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. Ann Rheum Dis. 55:243-247.
58. Nakayama T, Hashimoto S, Amemiya E, Horie T. 1996 Evaluation of plasma-soluble tumour necrosis factor receptors (TNF-R) in sarcoidosis. Clin Exp Immunol. 104:318-324.
59. Salles G, Bienvenu J, Bastion Y, et al. 1996 Elevated circulating levels of TNFalfa and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients. Br J Hematol. 93:352-359.
60. Bemelmans MH, Greve JW, Gouma DJ, Buurman WA. 1996 Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. Gut. 38:447-453.
61. Deloron P, Roux Lombard P, Ringwald P, et al. 1994 Plasma levels of TNF-alpha soluble receptors correlate with outcome in human falciparum malaria. Eur Cytokine Netw. 5:331-336.
62. Staal-van der Brekel AJ, Dentener MA, Scho's AM, Buurman WA, Wouters EF. 1995 Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients. J Clin Oncol. 13:2600-2605.
63. Denz H, Orth B, Weiss G, et al. 1993 Serum soluble tumour necrosis factor receptor 55 is increased in patients with haematological neoplasias and is associated with immune activation and weight loss. Eur J Cancer. 29A:2232-2235.
64. Grunfeld C, Pang M, Shigenaga JK, et al. 1996 Serum leptin levels in the acquired immunodeficiency syndrome. J Clin Endocrinol Metab. 81:4342-4346.
65. Rosenbaum M, Nicolson M, Hirsch J, et al. 1996 Effects of gender, body composition and menopause on plasma concentrations of leptin. J Clin Endocrin Metab. 81:3424-3427.
66. Rothwell NJ, Luheshi G, Toulmond S. 1996 Cytokines and their receptors in the central nervous system: physiology, pharmacology and pathology. Pharmacol Ther. 69:85-95.